YY1 and glioblastoma: In an orthotopic GBM mice model, when combined with TMZ or radiotherapy, the engineered exosomes efficiently delivered cholesterol-modified siYY1, leading to a synergistic inhibition of GBM growth by targeting the knockdown of YY1 [15].